Cantitate/Preț
Produs

Advances in Studies on Enzyme Inhibitors as Drugs: Volume 1: Anticancer & Antiviral Drugs

Editat de Satya P Gupta
en Limba Engleză Hardback – 2017
This book which is edited by eminent scientist Satya P. Gupta, covers the most recent development on design and discovery of the most useful drugs acting against several life threatening diseases such as cancer, viral infections and many others in two volumes. All of these drugs are based on inhibitions of various enzymes. Most human diseases are found to be associated with the overexpression of the enzymes. The book presents the structural aspects of various enzymes, their active sites, and the structural requirements of chemicals for strong interactions with enzymes. Volume One contains twelve chapters related to enzyme inhibitors acting as anticancer and antiviral drugs (each written by highly acclaimed authors), and Volume Two contains ten chapters on enzyme inhibitors acting against miscellaneous diseases written by equally competent authors. The book may be an asset for drug industries, research organisations, and individual researchers.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Hardback (2) 159571 lei  3-5 săpt.
  Nova Science Publishers Inc – 2017 159571 lei  3-5 săpt.
  Nova Science Publishers Inc – 2017 159682 lei  3-5 săpt.

Preț: 159682 lei

Preț vechi: 185393 lei
-14% Nou

Puncte Express: 2395

Preț estimativ în valută:
30563 31497$ 25803£

Carte disponibilă

Livrare economică 08-22 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781536105049
ISBN-10: 153610504X
Pagini: 340
Dimensiuni: 180 x 260 x 27 mm
Greutate: 0.82 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers Inc

Cuprins

Preface; Mitogen-Activated Protein Kinase (MAPK) Inhibitors for The Treatment of Advanced Hepatocellular Carcinoma; Protein Farnesyltransferase Inhibitors as Novel Anticancer Chemotherapeutics; Peptidylarginine Deiminase (PAD) Inhibitors; Interfering with Enzymatic Steps of Micrornas Pathway Using Small Molecules; In Silico Studies for the Discovery of Leads to Inhibit Cyclin-Dependent Kinase 2 (CDK2); Design & Development of Tyrosine Kinase Inhibitors as Anticancer Drugs; In Silico Design of Carbonic Anhydrase Inhibitors as Antitumor Drugs; Studies on Inhibitors of Dengue Virus Protease; Design & Development of Inhibitors of Picornavirus Proteases; Neuraminidase Inhibitors: From Research Tools to Drug Candidates; Recent Developments in HIV-1 Integrase Inhibitors; Studies on Dual Inhibitors of HIV Reverse Transcriptase & Integrase; Index.